Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/μL

Mark A. Jacobson, David Hardy, Elizabeth Connick, Jessica Watson, Michael DeBruin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1070-1076
Number of pages7
JournalJournal of Infectious Diseases
Volume182
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Cite this